Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer s amyloid beta-peptide elimination from the brain Zlokovic BV; Deane R; Sagare AP; Bell RD; Winkler EAJ Neurochem 2010[Dec]; 115 (5): 1077-89Low-density lipoprotein receptor-related protein-1 (LRP1), a member of the low-density lipoprotein receptor family, has major roles in the cellular transport of cholesterol, endocytosis of 40 structurally diverse ligands, transcytosis of ligands across the blood-brain barrier, and transmembrane and nuclear signaling. Recent evidence indicates that LRP1 regulates brain and systemic clearance of Alzheimer's disease (AD) amyloid beta-peptide (Abeta). According to the two-hit vascular hypothesis for AD, vascular damage precedes cerebrovascular and brain Abeta accumulation (hit 1) which then further amplifies neurovascular dysfunction (hit 2) preceding neurodegeneration. In this study, we discuss the roles of LRP1 during the hit 1 and hit 2 stage of AD pathogenesis and describe a three-level serial LRP1-dependent homeostatic control of Abeta clearance including (i) cell-surface LRP1 at the blood-brain barrier and cerebrovascular cells mediating brain-to-blood Abeta clearance (ii) circulating LRP1 providing a key endogenous peripheral 'sink' activity for plasma Abeta which prevents free Abeta access to the brain, and (iii) LRP1 in the liver mediating systemic Abeta clearance. Pitfalls in experimental Abeta brain clearance measurements with the concurrent use of peptides/proteins such as receptor-associated protein and aprotinin are also discussed. We suggest that LRP1 has a critical role in AD pathogenesis and is an important therapeutic target in AD.|Alzheimer Disease/*pathology/physiopathology[MESH]|Amyloid beta-Peptides/*metabolism[MESH]|Animals[MESH]|Brain/*metabolism[MESH]|Homeostasis/*physiology[MESH]|Humans[MESH]|LDL-Receptor Related Protein-Associated Protein/*metabolism[MESH] |